Cervical disease is a common disease of women, in a variety of malignant tumors in women, cervical cancer incidence after breast cancer, ran
Cervical disease is a common disease of women, in a variety of malignant tumors in women, cervical cancer incidence after breast cancer, ranked second, and young patients in recent years is a clear upward trend, 80% of patients were diagnosed as invasive cancer development (i.e., diffusion, influence of life) and from the cervical precancerous lesions develop into cervical cancer for 10 years, so the early diagnosis and treatment of cervical precancerous lesions is an important measure to reduce the incidence of cervical cancer.
Very early cervical cancer can be asymptomatic or only watery vaginal discharge or bleeding after sexual intercourse, these symptoms are often ignored by patients. However, due to the easy exposure of the cervix, cervical cytology and cervical biopsy, usually can make accurate diagnosis. In the United States, women who start having sex are required to have a cervical cancer cytology every year. TCT is the abbreviation of ThinPrep cytology test, cervical cells by TCT detection system and cytological diagnosis, it is a kind of cervical cancer cytology technology is currently the most advanced, and the traditional cervical scraping smear tests was higher than the specimen's satisfaction and detection rate of abnormal cervical cells.
The incidence of cervical cancer in developed countries generally carried out with screening showed a downward trend, but in a developing country with a large population, because screening is not enough, the incidence of cervical cancer is still worrying, the annual number of deaths from cervical cancer of 270 thousand cases. The effective rate of the patients with early stage cervical cancer (stage I and II) was 80%, but the cure rate of stage III was only about 60%. It is worth looking forward to, for human papilloma virus (HPV) immune therapy can prevent high risk HPV infection, is expected to prevent certain HPV caused by cervical cancer.